ACC’s Clinical Mobile Apps
The ACC has partnered with various organizations to create a variety of resources optimized for smart phones and tablets.
The ASCVD Risk Estimator is published jointly by the American College of Cardiology (ACC) and the American Heart Association (AHA) to help health care providers and patients estimate 10-year and lifetime risks for atherosclerotic cardiovascular disease (ASCVD) using the Pooled Cohort Equations and lifetime risk prediction tools. This app is intended as a companion tool to the 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk and the 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults.
The ASCVD Risk Estimator provides easy access to recommendations specific to calculated risk estimates. Additionally, the app includes readily accessible guideline reference information for both providers and patients related to therapy, monitoring, and lifestyle.
Find out more >>>
Available exclusively to ACC members using their ACC.org username and password, this app is designed to enhance the clinician/patient relationship at the point of care. By using the app's high resolution cardiac graphics and animations, physicians can effectively review and discuss common heart problems and treatment options with their patients. This app is available for download on iPad2, the new iPad, or iOS version 5.0 or higher.
The FOCUS App is a decision support tool for clinicians that helps guide and improve appropriate ordering of cardiovascular imaging and tests. The app provides official ACC Appropriate Use Criteria (AUC) ratings and decision algorithms for SPECT MPI, PET, stress echo and CTA to drive clinical decision making for your patient. It automatically calculates risk and pretest probability based on the patient's age, gender and clinical risk factors to derive accurate AUC ratings. The app is currently available for use on iPad.
New! The ACC Statin Intolerance App guides clinicians through the process of managing and treating patients who report muscle symptoms while on statin therapy. Clinicians can use the app to evaluate possible intolerance to a patient’s current statin prescription, follow steps to manage and treat a patient who reports muscle symptoms on a statin, and compare statin characteristics and drug interactions to inform management of LDL-related risk. Information in the app is derived from ACC/AHA cholesterol guidelines and best practices.
Find out more >>>
Click here to explore ACC's suite of mobile apps >>>